refractory anaemia with excess blasts

(medicine) One of the myelodysplastic syndromes, namely having between 5-20% myeloblasts in the bone marrow; by the WHO further subdivided in RAEB-1 and RAEB-2, with 5-9% and 10-19% blasts, respectively.